Background
At present, the preferred method for the clinical treatment of toxoplasmosis is still drug therapy such as pyrimethamine and sulfadiazine, but there are problems such as large side effects and drug resistance. Terpenoids are distributed in nature and a large number of studies have shown that they have effective inhibitory effects on various parasites.
Methods
In this study, we used small-molecule intermediate products of natural terpenoid chlorajaponilide C to evaluate their cytotoxicity and their intracellular and extracellular inhibitory effects on Toxoplasma gondii tachyzoites.
Results
We demonstrated that two of these target compounds could induce tachyzoite apoptosis probably by altering tachyzoite mitochondrial membrane potential, calcium homeostasis, and lipid metabolism, effectively reducing the number of extracellular tachyzoites. In addition, the two target compounds were also able to effectively clear intracellular tachyzoites, possibly enhancing this effect by interacting with the host cell's immune system.
Conclusions
Two terpenoid natural products with low cytotoxicity had direct and indirect anti-toxoplasma effects and were expected to further evaluate their potential for the treatment of toxoplasmosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.